» Articles » PMID: 38888670

Osteosarcopenia Increases the Risk of Mortality: a Systematic Review and Meta-analysis of Prospective Observational Studies

Overview
Publisher Springer
Specialty Geriatrics
Date 2024 Jun 18
PMID 38888670
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Osteosarcopenia is a recently recognized geriatric syndrome. The association between osteosarcopenia and mortality risk is still largely underexplored. In this systematic review with meta-analysis of prospective cohort studies, we aimed to explore whether osteosarcopenia could be associated with a higher mortality risk.

Methods: Several databases were searched from the inception to 16th February 2024 for prospective cohort studies dealing with osteosarcopenia and mortality. We calculated the mortality risk in osteosarcopenia vs. controls using the most adjusted estimate available and summarized the data as risk ratios (RRs) with their 95% confidence intervals (CIs). A random-effect model was considered for all analyses.

Results: Among 231 studies initially considered, nine articles were included after exclusions for a total of 14,429 participants (mean age: 70 years; 64.5% females). The weighted prevalence of osteosarcopenia was 12.72%. Over a mean follow-up of 6.6 years and after adjusting for a mean of four covariates, osteosarcopenia was associated with approximately 53% increased risk of mortality (RR: 1.53; 95% CI: 1.28-1.78). After accounting for publication bias, the re-calculated RR was 1.48 (95%CI: 1.23-1.72). The quality of the studies was generally good, as determined by the Newcastle Ottawa Scale.

Conclusions: Osteosarcopenia was significantly linked with an increased risk of mortality in older people, indicating the need to consider the presence of osteoporosis in patients with sarcopenia, and vice versa, since the combination of these two conditions typical of older people may lead to further complications, such as mortality.

Citing Articles

Ten-year atherosclerotic cardiovascular disease risk score in post-menopausal women with low bone mineral density.

Wani K, Sabico S, Veronese N, Al-Masri A, Al-Daghri N Aging Clin Exp Res. 2025; 37(1):56.

PMID: 40011291 PMC: 11865107. DOI: 10.1007/s40520-025-02957-1.

References
1.
James S, Lucchesi L, Bisignano C, Castle C, Dingels Z, Fox J . The global burden of falls: global, regional and national estimates of morbidity and mortality from the Global Burden of Disease Study 2017. Inj Prev. 2020; 26(Supp 1):i3-i11. PMC: 7571347. DOI: 10.1136/injuryprev-2019-043286. View

2.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10(1):89. PMC: 8008539. DOI: 10.1186/s13643-021-01626-4. View

3.
Hirschfeld H, Kinsella R, Duque G . Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017; 28(10):2781-2790. DOI: 10.1007/s00198-017-4151-8. View

4.
Cumpston M, Li T, Page M, Chandler J, Welch V, Higgins J . Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019; 10:ED000142. PMC: 10284251. DOI: 10.1002/14651858.ED000142. View

5.
Nakano Y, Mandai S, Naito S, Fujiki T, Mori Y, Ando F . Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults. Bone. 2023; 179:116975. DOI: 10.1016/j.bone.2023.116975. View